Skip to content

PATH Partnering to Achieve Tobacco-free Health

Acceptance & Commitment Therapy for Smoking Cessation (Aka PATH Study - Partnering to Achieve Tobacco-free Health)

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01533974
Acronym
PATH
Enrollment
450
Registered
2012-02-16
Start date
2011-06-30
Completion date
2015-01-31
Last updated
2016-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Brief summary

The overall aim of this 5-year project is to capitalize on the strong theoretical and promising empirical evidence for Acceptance & Commitment Therapy (ACT) as an intervention for smoking cessation by comparing the effectiveness of ACT against standard cognitive behavioral therapy (CBT) counseling when both are offered with nicotine replacement therapy (NRT) and delivered within a real world healthcare setting.

Interventions

OTHERAcceptance & Commitment Therapy (ACT)

We will use a five-session (90 minutes per session) group-delivered adaptation of Dr. Bricker's ACT treatment program.

OTHERCognitive Behavioral Therapy (CBT)

The control condition will be the current group-delivered CBT smoking cessation program at GH.

Sponsors

Kaiser Permanente
CollaboratorOTHER
Fred Hutchinson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. aged 18 and older; 2. smoke at least 10 cigarettes per day for every day in the past month; 3. want to quit smoking in the next 30 days; 4. are able to speak and read in English; 5. are a GH member enrolled living in the greater Seattle area; 6. are not currently participating in other smoking cessation interventions; 7. not currently using other nicotine products (e.g., smokeless tobacco) 8. are willing to attend five 90-minute group intervention sessions and to receive NRT over the next 3 months; 9. have no medical contraindications for NRT use (i.e., pregnant, breastfeeding, recent heart attack, or skin allergy preventing use of the patch, as assessed using the standard GH contraindication screening for NRT patch); 10. no household member currently enrolled in the study

Exclusion criteria

1. fails to meet the eligibility criteria above; 2. has a significant cognitive or physical impairment (e.g., dementia, deafness) that would preclude full participation in the counseling sessions. This will be assessed both by self-report and by in-person assessment at the baseline enrollment appointment

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Who Stopped Smoking by 12 Month Post Treatment12 months30 day point prevalence abstinence at 12 months. Missing = smoking and self report.

Countries

United States

Participant flow

Participants by arm

ArmCount
Acceptance and Commitment Therapy (ACT)
We will use a five-session (90 minutes per session) group-delivered adaptation of Dr. Bricker's ACT treatment program. Acceptance & Commitment Therapy (ACT): We will use a five-session (90 minutes per session) group-delivered adaptation of Dr. Bricker's ACT treatment program.
224
Cognitive Behavioral Therapy (CBT)
Cognitive Behavioral Therapy (CBT): The control condition will be the current group-delivered CBT smoking cessation program at GH.
226
Total450

Baseline characteristics

CharacteristicAcceptance and Commitment Therapy (ACT)Cognitive Behavioral Therapy (CBT)Total
Age, Continuous51.8 years
STANDARD_DEVIATION 12
50.8 years
STANDARD_DEVIATION 12.2
51.3 years
STANDARD_DEVIATION 12.1
Sex: Female, Male
Female
118 Participants119 Participants237 Participants
Sex: Female, Male
Male
106 Participants107 Participants213 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
17 / 2245 / 226
serious
Total, serious adverse events
0 / 2240 / 226

Outcome results

Primary

Number of Participants Who Stopped Smoking by 12 Month Post Treatment

30 day point prevalence abstinence at 12 months. Missing = smoking and self report.

Time frame: 12 months

ArmMeasureValue (NUMBER)
Acceptance and Commitment Therapy (ACT)Number of Participants Who Stopped Smoking by 12 Month Post Treatment31 participants
Cognitive Behavioral Therapy (CBT)Number of Participants Who Stopped Smoking by 12 Month Post Treatment41 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026